首页> Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer> Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?

Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?

导出原文传递

翻译打印收藏纠错

第一作者： Rainer J,Klement

第一单位： Department of Radiation Oncology, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany.

作者： Rainer J,Klement ^[1] ; José,Belderbos ^[2] ; Inga,Grills ^[3] ; Maria,Werner-Wasik ^[4] ; Andrew,Hope ^[5] ; Meredith,Giuliani ^[5] ; Hong,Ye ^[3] ; Jan-Jakob,Sonke ^[2] ; Heike,Peulen ^[2] ; Matthias,Guckenberger ^[6]

作者单位： Department of Radiation Oncology, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany. ^[1] Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. ^[2] William Beaumont Hospital, Royal Oak, Michigan. ^[3] Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. ^[4] University of Toronto and Princess Margaret Cancer Center, Toronto, Canada. ^[5] Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: Matthias.Guckenberger@usz.ch. ^[6]

关键词 LASSO method Logistic regression Non–small cell lung cancer Overall survival Stereotactic body radiotherapy